Literature DB >> 27412572

The emerging roles of Jab1/CSN5 in cancer.

Lin Wang1, Jun-Nian Zheng2,3,4, Dong-Sheng Pei5,6,7.   

Abstract

C-Jun activation domain-binding protein-1 (Jab1) not only is full but also a subunit (CSN5) of the constitutive photomorphogenesis 9 signalosome (CSN), which is an evolutionarily conserved and multifunctional protein that involves in controlling cellular proliferation and apoptosis, affecting a series of pathways, as well as regulating genomic instability and DNA damage and repair. The CSN is a highly conservative protein from yeast to human and interacts with the cullin-RING family of ubiquitin ligases so that it could be execute a process of removing NEDD8, a ubiquitin-like polypeptide (deneddylase activity). The role of Jab1/CSN5's multi-function has been proved as being oncogenic in nature, what is more, Jab1/CSN5 has been confirmed by much evidence that it participates in the carcinogenesis progression and is tightly associated with poor prognosis. However, the biologic implication of Jab1/CSN5 activity during the cancer's development is unclear. We performed a systematic literature review and assessment from PubMed and Medline databases in this article. Jab1/CSN5 is participate in a lot of biologic responses, including cell proliferation, apoptosis, cell cycle regulation, DNA metabolism, invasion, DNA damage and repair, and recurrence. It also promotes cell transformation and tumorigenesis. In this review, we mainly expound the progress in the function and research advances of Jab1/CSN5 and in untangling the Jab1/CSN5 signaling pathway. Based on these bases, its potential as a therapeutic target for cancer can play a greater role in future cancer treatment.

Entities:  

Keywords:  Cancer; Cell cycle; DDR; Jab1/CSN5; Proliferation; Ubiquitination

Mesh:

Substances:

Year:  2016        PMID: 27412572     DOI: 10.1007/s12032-016-0805-1

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  100 in total

1.  Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53.

Authors:  S Fang; J P Jensen; R L Ludwig; K H Vousden; A M Weissman
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

Review 2.  COP9 signalosome revisited: a novel mediator of protein degradation.

Authors:  C Schwechheimer; X W Deng
Journal:  Trends Cell Biol       Date:  2001-10       Impact factor: 20.808

3.  Structure of cDNAs encoding human eukaryotic initiation factor 3 subunits. Possible roles in RNA binding and macromolecular assembly.

Authors:  K Asano; H P Vornlocher; N J Richter-Cook; W C Merrick; A G Hinnebusch; J W Hershey
Journal:  J Biol Chem       Date:  1997-10-24       Impact factor: 5.157

4.  Macrophage migration inhibitory factor in prostatic adenocarcinoma: correlation with tumor grading and combination endocrine treatment-related changes.

Authors:  M T del Vecchio; S A Tripodi; F Arcuri; L Pergola; L Hako; R Vatti; M Cintorino
Journal:  Prostate       Date:  2000-09-15       Impact factor: 4.104

5.  Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity.

Authors:  H Lue; M Thiele; J Franz; E Dahl; S Speckgens; L Leng; G Fingerle-Rowson; R Bucala; B Lüscher; J Bernhagen
Journal:  Oncogene       Date:  2007-02-19       Impact factor: 9.867

6.  Roles for CSN5 in control of p53/MDM2 activities.

Authors:  Xiao-Chun Zhang; Jian Chen; Chun-Hui Su; Heng-Yin Yang; Mong-Hong Lee
Journal:  J Cell Biochem       Date:  2008-03-01       Impact factor: 4.429

7.  The COP9 signalosome promotes degradation of Cyclin E during early Drosophila oogenesis.

Authors:  Sergey Doronkin; Inna Djagaeva; Steven K Beckendorf
Journal:  Dev Cell       Date:  2003-05       Impact factor: 12.270

Review 8.  The COP9 signalosome.

Authors:  Ning Wei; Xing Wang Deng
Journal:  Annu Rev Cell Dev Biol       Date:  2003       Impact factor: 13.827

9.  Macrophage migration inhibitory factor promotes intestinal tumorigenesis.

Authors:  Jonathan M Wilson; P Louise Coletta; Richard J Cuthbert; Nigel Scott; Kenneth MacLennan; Gillian Hawcroft; Lin Leng; Jodi B Lubetsky; Kai K Jin; Elias Lolis; Francisco Medina; Jose A Brieva; Richard Poulsom; Alexander F Markham; Richard Bucala; Mark A Hull
Journal:  Gastroenterology       Date:  2005-11       Impact factor: 22.682

10.  CSN5/Jab1 mutations affect axis formation in the Drosophila oocyte by activating a meiotic checkpoint.

Authors:  Sergey Doronkin; Inna Djagaeva; Steven K Beckendorf
Journal:  Development       Date:  2002-11       Impact factor: 6.868

View more
  13 in total

1.  Chemogenomic study of gemcitabine using Saccharomyces cerevisiae as model cell-molecular insights about chemoresistance.

Authors:  Lucas de Sousa Cavalcante; Tales A Costa-Silva; Tiago Antônio Souza; Susan Ienne; Gisele Monteiro
Journal:  Braz J Microbiol       Date:  2019-09-12       Impact factor: 2.476

2.  JAB1 promotes palmitate-induced insulin resistance via ERK pathway in hepatocytes.

Authors:  Yun Zhao; Suxian Ma; Xingna Hu; Min Feng; Rong Xiang; Min Li; Chenxiao Liu; Ting Lu; Aijie Huang; Jiaqi Chen; Mian Wu; Honghong Lu
Journal:  J Physiol Biochem       Date:  2020-10-14       Impact factor: 4.158

Review 3.  Jab1/Cops5: a promising target for cancer diagnosis and therapy.

Authors:  Chunjue Yuan; Dong Wang; Guohong Liu; Yunbao Pan
Journal:  Int J Clin Oncol       Date:  2021-05-21       Impact factor: 3.402

Review 4.  Jab1/COPS5 as a Novel Biomarker for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Human Cancer.

Authors:  Guohong Liu; Francois X Claret; Fuling Zhou; Yunbao Pan
Journal:  Front Pharmacol       Date:  2018-02-27       Impact factor: 5.810

5.  α5-nAChR contributes to epithelial-mesenchymal transition and metastasis by regulating Jab1/Csn5 signalling in lung cancer.

Authors:  Xiaowei Chen; Yanfei Jia; Yujie Zhang; Dajie Zhou; Haiji Sun; Xiaoli Ma
Journal:  J Cell Mol Med       Date:  2020-01-13       Impact factor: 5.310

6.  CSN6 promotes the cell migration of breast cancer cells by positively regulating Snail1 stability.

Authors:  Jie Mou; Lulu Wei; Jia Liang; Wenqi Du; Dongsheng Pei
Journal:  Int J Med Sci       Date:  2020-10-01       Impact factor: 3.738

Review 7.  MIF-Dependent Control of Tumor Immunity.

Authors:  Jordan T Noe; Robert A Mitchell
Journal:  Front Immunol       Date:  2020-11-25       Impact factor: 7.561

8.  Prognostic Significance of CSN2, CD8, and MMR Status-Associated Nomograms in Patients with Colorectal Cancer.

Authors:  Bing Zhu; Pei Zhang; Mulin Liu; Congqiao Jiang; Hao Liu; Jun Fu
Journal:  Transl Oncol       Date:  2018-07-31       Impact factor: 4.243

9.  Overexpression of JAB1 promotes malignant behavior and predicts poor prognosis in esophageal squamous cell carcinoma.

Authors:  Qi Shen; Bin Shang; Bin Jiang; Yu Wang; Zhou Wang; Gang Chen
Journal:  Thorac Cancer       Date:  2020-02-16       Impact factor: 3.500

10.  CSN1 facilitates proliferation and migration of hepatocellular carcinoma cells by upregulating cyclin A2 expression.

Authors:  Hangwei Fu; Yida Zhang; Yin Chen; Junying Chen; Ping Chen
Journal:  Mol Med Rep       Date:  2020-11-17       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.